Covid-19 vaccine India update: PGI Rohtak to start phase-2 trial of Bharat Biotech's Covaxin

- The phase 2 human clinical trial of Bharat Biotech's coronavirus vaccine Covaxin at PGI Rohtak will involve 300 volunteers
- Covaxin is one of the frontrunners in the race for a Covid-19 vaccine in India